United Therapeutics Corp

NASDAQ:UTHR   3:59:50 PM EDT
190.60
-0.74 (-0.39%)
Products

Liquidia Receives Favorable Ruling In Inter Partes Review Against United Therapeutics Patent

Published: 10/08/2021 21:37 GMT
United Therapeutics Corp (UTHR) - Liquidia Receives Favorable Ruling in Inter Partes Review Against United Therapeutics Patent.
Liquidia Corp - in Its Ruling, Ptab Found That Seven of Nine Claims Were Unpatentable.
Liquidia Corp - Ptab's Decision With Respect to '901 Patent Does Not Resolve On-going Litigation Brought by Utc Related to Liq861.